A0A0K0K1A5 (TVB65_HUMAN) Homo sapiens (Human)
T cell receptor beta variable 6-5 UniProtKBInterProInteractive Modelling
114 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
18 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Human Leukocyte Antigen A02 presenting ILAKFLHWL, in complex with cognate T-Cell Receptor |
Heteromer A0A0B4J277; K7N5M3; K7N5M4; O14746; P04439; P61769; | 100 | 5×EDO; 1×GOL; 5×SO4; | |||
| Structural and kinetic basis for heightened immunogenicity of T cell vaccines |
Heteromer A0A0B4J279; P01848; P01850; | 100 | ||||
| Structural and kinetic basis for heightened immunogenicity of T cell vaccines |
Heteromer A0A0B4J279; P01848; P01850; P04439; P61769; P78358; | 100 | ||||
| Structural and kinetic basis for heightened immunogenicity of T cell vaccines |
Heteromer A0A0B4J279; P01848; P01850; P04439; P61769; P78358; | 100 | ||||
| COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7, VIRAL PEPTIDE (TAX) AND MHC CLASS I MOLECULE HLA-A 0201 |
Heteromer A0A5B9; P01848; P04437; P04439; P14079; P61769; | 100 | ||||
| Engineered Human HLA_A2 MHC Class I molecule in complex with TCR and SV9 peptide |
Heteromer A0A0B4J279; K7N5M4; K7N5N2; P04439; P61769; | 100 | 1×GOL; 1×ACT; | |||
| COMPLEX BETWEEN HUMAN T-CELL RECEPTOR, VIRAL PEPTIDE (TAX), AND HLA-A 0201 |
Heteromer A0A075B6T6; A0A5B9; P01848; P04439; P14079; P61769; | 97.85 | 2×EMC; | |||
| RD-1 Mart-1 High bound to Mart-1 decameric peptide (ELA) in complex with HLA-A2 |
Heteromer A0A075B6T6; P04439; P61769; Q16655; | 94.56 | ||||
| Crystal structure of human TCR Alpha Chain-TRAV12-3, Beta Chain-TRBV6-5, Antigen-presenting molecul… |
Heteromer A0A0B4J271; A0A5B9; P01848; P15813; P61769; | 100 | 2×NAG; 1×JLS; | |||
| TCR in nanodisc ND-I |
Heteromer P01848; P04234; P07766; P09693; P0DTU4; P20963; | 100.0 | 2×NAG; 1×NAG; 3×NAG; 2×CLR; | |||
| TCR in complex with HLA-E*01:03 bound to HBV envelope 371-379 index peptide |
Heteromer A0A075B6T6; P0DTU3; P0DTU4; P13747; P61769; Q67953; | 96.7 | ||||
| TCR in complex with HLA-E*01:03 bound to HBV envelope 371-379 S3N peptide |
Heteromer A0A075B6T6; P0DTU3; P0DTU4; P13747; P61769; Q67953; | 96.7 | ||||
| TCR in complex with HLA-E*01:03 bound to HBV envelope 371-379 L6I peptide |
Heteromer A0A075B6T6; P0DTU3; P0DTU4; P13747; P61769; Q67953; | 96.7 | ||||
| Cryo-EM structure of a membrane protein(CS) |
Heteromer A0A0B4J271; A0N4Z6; P01848; P04234; P07766; P09693; P0DSE2; P20963; | 100 | 2×C3S; | |||
| Cryo-EM structure of a membrane protein(WT) |
Heteromer A0A0B4J271; A0N4Z6; P01848; P04234; P07766; P09693; P0DSE2; P20963; | 100 | 2×CLR; | |||
| Cryo-EM structure of a membrane protein(LL) |
Heteromer A0A0B4J271; A0N4Z6; P01848; P04234; P07766; P09693; P0DSE2; P20963; | 100 | 1×CLR; | |||
| Structure of human T cell receptor-CD3 complex |
Heteromer A0A0B4J271; A0N4Z6; P01848; P04234; P07766; P09693; P0DSE2; P20963; | 100 | ||||
| TCR in nanodisc ND-II |
Heteromer P04234; P07766; P09693; P0DTU4; P20963; | 100.0 | 1×NAG; 2×CLR; 1×NAG; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 9c3e.1.B | monomer | 0.83 | 100.00 | |||